ArticleFrontiers in public health2026
Long-term public antibiotic awareness campaign significantly reduced inappropriate antibiotic use in pediatric primary care settings.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibiotic Resistance Profiles of Invasive Bacterial Isolates from Hospitalized Pediatric Patients in Serbia: A Multicenter Surveillance Study, 2020-2024.Antibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Serbia, like most countries in Southern Europe, has faced persistently high rates of antibiotic consumption. Previous analyses revealed that most antibiotics were prescribed inappropriately, mainly for influenza-like illnesses. Methods: The first short term media antibiotic awareness campaign (AAC) was held in 2011 and 2014 respectively. Shortly after, in November 2015, the Serbian Ministry of Health launched a nationwide public AAC. The campaign adapted the European Centre for Disease Prevention and Control (ECDC) and World Health Organization (WHO) communication platforms, methodological frameworks, and promotional materials under the motto "Careful with Antibiotics." Results: In addition to 423 media features, the campaign encompassed professional education, as well as the development of national guidelines and regulations. Educational activities targeting the public and healthcare professionals (2,119 pediatricians, 428 nurses, and 6,083 pharmacists) were guided by prior analyses of pediatric antibiotic consumption. Over 6 years, 8,750 brochures, 5,500 posters, and more than 3,000 other educational materials were distributed to 158 primary-care centers, pharmacies and in public places nationwide. Long-term campaign interventions resulted in a 32.8% reduction in the number of systemic antibiotic prescriptions per 1,000 children between 2015 and 2021. The most pronounced declines were observed among younger children (2-23 months and 2-11 years respectively) aligning with the main target group of the educational efforts, which focused on young children, including preschool and early school-aged children, who had the highest baseline prescribing rates. Excluding the common cold, the significant decreases were recorded for pharyngitis, tonsillitis, otitis media, and bronchitis, conditions that previously accounted for most inappropriate antibiotic use. From 2011, Serbia's maximum 61% reduction in pediatric antibiotic prescription rates ranks among the most pronounced in Europe. Despite a gradual shift toward broader-spectrum agents, the Access-group share remained around 60% throughout most of the observation period. Conclusion: Serbia's long-term, multisectoral stewardship campaign achieved one of the largest and most sustained declines in pediatric antibiotic consumption across Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.